Arsenic Trioxide in Combination with All-Trans Retinoic Acid for the Treatment of Newly Diagnosed Patients with High-Risk APL By Ogkologos - September 3, 2025 376 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the APOLLO study Source RELATED ARTICLESMORE FROM AUTHOR Significant PFS Improvement with Ibrutinib-Rituximab Compared to Immunochemotherapy in Previously Untreated Patients with Mantle Cell Lymphoma EMA Recommends a Change to the Terms of the Marketing Authorisation for Mosunetuzumab Combining Niraparib with Abiraterone Acetate and Prednisone Significantly Improves rPFS in Patients with mCSPC Harbouring BRCA1/2 or Other HRR Gene Alterations MOST POPULAR Laser-Based Device Detects and Kills Melanoma Cells in the Blood, Study... July 25, 2019 FDA Approves Durvalumab for Locally Advanced or Metastatic Biliary Tract Cancer September 14, 2022 Brain Cancer Cells Hijack Gene “On Switches” to Drive Tumor Growth January 6, 2020 New Research Looks for More Effective Breast Cancer Treatments for Black... January 12, 2021 Load more HOT NEWS Getting Help for Sexual Health Problems When You Have Head and... Bringing a Piece of Home to the Hospital NRG1 Fusion–positive Lung Cancers are Molecularly, Pathologically, and Clinically More Heterogeneous... seven Interesting Facts about Malignant tumors Boy Between the sheets
